Ftse Mib
36.471,75
0,12%
DAX
21.732,05
0,01%
S&P 500
6.040,53
-0,50%
NASDAQ
19.627,44
-0,28%
Bitcoin
102.367,35
-0,05%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. AMEX Serina Therapeutics Inc (SER) Serina Therapeutics Inc (SER) Notizie

Serina Therapeutics Inc

SER
4,70
0,10 (2,17%)
01 Feb 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: AMEX
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
15/1/202522:05GLOBESerina Therapeutics Announces Sale of UniverXome Subsidiary
14/1/202523:25GLOBESerina Therapeutics Welcomes Karen J. Wilson to its Board of..
06/1/202522:07EDGAR2Form 8-K - Current report
18/12/202422:16EDGAR2Form 8-K - Current report
16/12/202412:00GLOBESerina Therapeutics to Present at Tribe Public’s Webinar..
11/12/202412:05GLOBESerina Therapeutics to Present at the 3rd Annual LNP..
09/12/202422:45EDGAR2Form SC 13D/A - General Statement of Acquisition of..
02/12/202423:22GLOBESerina Therapeutics Secures $10 Million Financing to..
02/12/202423:16EDGAR2Form 8-K - Current report
22/11/202422:15EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
12/11/202423:05EDGAR2Form 8-K - Current report
12/11/202423:00GLOBESerina Therapeutics Reports Third Quarter 2024 Financial..
12/11/202422:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/11/202423:40GLOBESerina Therapeutics Makes Grants to New Employees Under..
06/11/202422:45EDGAR2Form ARS - Annual Report to Security Holders
06/11/202422:31EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
06/11/202412:32EDGAR2Form DEF 14A - Other definitive proxy statements
01/11/202414:15EDGAR2Form DEFC14A - Definitive proxy statement, contested..
02/10/202414:30EDGAR2Form 8-K - Current report
02/10/202414:30GLOBESerina Therapeutics to Present at the 14th Annual..
17/9/202400:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/9/202423:17EDGAR2Form 8-K - Current report
05/9/202400:42GLOBESerina Therapeutics to Present at the H.C. Wainwright 26th..
23/8/202423:21EDGAR2Form S-8 - Securities to be offered to employees in employee..
20/8/202400:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/8/202422:25EDGAR2Form 8-K - Current report
09/8/202422:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202422:15GLOBESerina Therapeutics Reports Second Quarter 2024 Financial..
29/7/202414:30EDGAR2Form 8-K - Current report
29/7/202414:30GLOBESerina Therapeutics to Present Novel Data on POZ-Lipid..
18/7/202423:06EDGAR2Form 8-K - Current report
18/7/202423:00GLOBESerina Therapeutics Appoints Srini Tenjarla, Ph.D. as Senior..
17/7/202423:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/7/202422:52EDGAR2Form 8-K - Current report
23/5/202423:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/5/202422:25EDGAR2Form 8-K - Current report
14/5/202422:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/5/202422:05GLOBESerina Therapeutics Reports First Quarter 2024 Financial..
17/4/202422:05GLOBESerina Therapeutics Appoints Dr. Simba Gill as Executive..
26/3/202422:04GLOBESerina Therapeutics Announces Completion of Merger with AgeX..
Apertura: 4,61 Min: 4,61 Max: 4,9081
Chiusura: 4,60

La tua Cronologia

AMEX
SER
Serina Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci